Lupin Pharmaceuticals Inc. recalls Memantine Hydrochloride Extended Release Capsules, 21 mg, 30-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuti
Recalled February 19, 2020 · FDA recall D-0855-2020 · Lupin Pharmaceuticals
Hazard
Failed Dissolution Specifications: Low out of specification results observed in dissolution test at six-month long-term stability study. · FDA Class II
Units
6,294 bottles
Sold at
Nationwide within the United States.
Description
Failed Dissolution Specifications: Low out of specification results observed in dissolution test at six-month long-term stability study.
Product
Memantine Hydrochloride Extended Release Capsules, 21 mg, 30-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States. Manufactured by: Lupin Limited Pithampur (M.P.)-454 775, INDIA, NDC 68180-248-06
Manufacturer(s)
Lupin Pharmaceuticals Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →